$DRK Balance Sheet | Understand Stock

$DRK

$1.94 -$0.02 (1.02%) Close

$DRK Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q3 FY2020 As of Sep 30, 2020	Q2 FY2020 As of Jun 30, 2020	Q1 FY2020 As of Mar 31, 2020
Cash and cash equivalents
Restricted Cash, Current
Investment in Equity Securities
Bitcoin
Accounts receivable, net
Inventories
Notes receivable
Other current assets
Total current assets
Note receivable
Investment
Property and equipment, net
Operating Lease, Right-of-Use Asset
Goodwill
Total intangible assets, net
Restricted Cash Trust Account
Long-term Investments
Other assets
Total assets
Accounts payable
Accrued liabilities
Accrued payroll and employee compensation
Deferred Revenue
Secured Debt, Current
Notes Payable, Related Parties, Current
Debt, Related Party
Line of credit
Warrant liabilities
Convertible debt
Other current liabilities
Total current liabilities
Deferred Underwriting Fee
Deferred Revenue, long-term
Unsecured Long-term Debt, Noncurrent
Convertible debt, long-term
Convertible Debt, Related Parties, Noncurrent
Other Non-current Liabilities
Operating Lease, Liability, Noncurrent
Deferred Income Tax Liabilities
Total liabilities
Preferred shares, no par value, unlimited shares authorized, 96,000 and 9,355,778 shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively
Series H Preferred Stock
Total preferred shares, no par value, unlimited shares authorized, 96,000 and 9,355,778 shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively
Series H preferred shares, no par value, unlimited shares authorized, 161 shares issued and outstanding as of June 30, 2026 and December 31, 2025
Series H Preferred Stock
Redeemable Noncontrolling Interest
Total series H preferred shares, no par value, unlimited shares authorized, 161 shares issued and outstanding as of June 30, 2026 and December 31, 2025
Preferred Stock, Value, Outstanding
Common shares, no par value; unlimited shares authorized, 7,639,893 and 3,392,541 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Accumulated other comprehensive loss
Accumulated deficit
Total shareholders’ equity
Non-controlling interest
Total liabilities, temporary equity, and shareholders’ equity

Comments